Search - tctmd.com

Displaying 701 - 720 of 984

Sort: Relevancy | Date

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

DAPT Study Subanalysis Focuses on EES Subgroup

October 12, 2015

Presentation TCT 2015

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Minh Vo

October 11, 2015

Presentation TCT 2015

PCI for Multivessel Disease With CTO: When and How? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Cheol Woong Yu

October 11, 2015

Presentation TCT 2015

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

Presenter: Thomas Engstroem, Manh-Hung Pham, Nhan Thanh Vo, Kevin Bainey

October 11, 2015

Presentation TCT 2015

How to Apply Physiology-Guided PCI for MVD

Presenter: Thomas Engstroem, Manh-Hung Pham, Chang-Wook Nam

October 11, 2015

Presentation TCT 2015

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Presenter: Thomas Engstroem, Manh-Hung Pham, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Complete vs Incomplete Revascularization

Presenter: Thomas Engstroem, Manh-Hung Pham, David A. Wood

October 11, 2015

Presentation TCT 2015

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Presenter: Taehoon Ahn, Robert C. Welsh, Quang Ngoc Nguyen

October 11, 2015

Presentation TCT 2015

Hybrid Revascularization Strategy for AMI Patients: How to Apply

Presenter: Taehoon Ahn, Robert C. Welsh, Christian Juhl Terkelsen

October 11, 2015

Presentation TCT 2015

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

Presenter: Taehoon Ahn, Robert C. Welsh, Leif Thuesen

October 11, 2015

Presentation TCT 2015

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Presenter: Taehoon Ahn, Robert C. Welsh, Young-Hak Kim

October 11, 2015

Presentation TCT 2015

Outcomes Have Always Been Better With CABG

Presenter: Taehoon Ahn, Robert C. Welsh, Samer Mansour

October 11, 2015

Presentation TCT 2015

Current Guideline Update

Presenter: Taehoon Ahn, Robert C. Welsh, Manh-Hung Pham

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Presenter: John A. Bittl, E. Magnus Ohman, Jorge F. Saucedo

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

Presenter: John A. Bittl, E. Magnus Ohman, Christoph A. Kaiser

October 11, 2015

News Conference News TCT 2015

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

October 11, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

Advertisement

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

DAPT Study Subanalysis Focuses on EES Subgroup

PCI for Multivessel Disease in the CABG Candidate: Should We Follow the Guidelines? With Case Examples

PCI for Multivessel Disease With CTO: When and How? With Case Examples

A Practical Stenting Issue in Multivessel Disease: When and Where to Stop? With Case Examples

How to Apply Physiology-Guided PCI for MVD

One-Stage vs Delayed PCI for Nonculprit Lesion in Patients With AMI and Multivessel Disease

Complete vs Incomplete Revascularization

Role of Bioresorbable Vascular Scaffolds in a Hybrid Revascularization Strategy

Hybrid Revascularization Strategy for AMI Patients: How to Apply

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

PCI May Be Considered in Challenging Patients With Triple-Vessel Disease

Outcomes Have Always Been Better With CABG

Current Guideline Update

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? No, the Risks Are Real and There Is No Evidence for Benefit!

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

SYNTAX Analysis: MI-Related Deaths More Common With PCI vs. CABG

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content